Standard BioTools Inc. Common Stock, Capital Shares Reserved for Future Issuance
Standard BioTools Inc. (LAB) had Common Stock, Capital Shares Reserved for Future Issuance of 25.42 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-05
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 25.42M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 16.18M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 25.12M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 24.12M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 25.42M shares 10-Q · filed 2026-08-05 |
| 2026-03-31 | 16.18M shares 10-Q · filed 2026-05-06 |
| 2025-12-31 | 25.12M shares 10-K · filed 2026-03-16 |
| 2025-09-30 | 24.12M shares 10-Q · filed 2025-11-04 |
| 2025-06-30 | 28.38M shares 10-Q · filed 2025-08-15 |
| 2025-03-31 | 11.95M shares 10-Q · filed 2025-05-06 |
| 2024-12-31 | 25.16M shares 10-K · filed 2025-03-11 |
| 2024-09-30 | 25.42M shares 10-Q · filed 2024-11-06 |
| 2024-06-30 | 30.07M shares 10-Q · filed 2024-08-06 |
| 2024-03-31 | 21.18M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 6.45M shares 10-K · filed 2024-03-01 |
| 2023-09-30 | 6.95M shares 10-Q · filed 2023-11-07 |
| 2023-06-30 | 10.08M shares 10-Q · filed 2023-08-08 |
| 2023-03-31 | 6.75M shares 10-Q · filed 2023-05-09 |
| 2022-12-31 | 5.93M shares 10-K · filed 2023-03-14 |
| 2022-09-30 | 7.53M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 6.63M shares 10-Q · filed 2022-08-09 |
| 2022-03-31 | 6.19M shares 10-Q · filed 2022-05-09 |
| 2021-12-31 | 6.15M shares 10-K · filed 2022-03-08 |
| 2021-09-30 | 6.33M shares 10-Q · filed 2021-11-09 |
| 2021-06-30 | 6.95M shares 10-Q · filed 2021-08-06 |
| 2021-03-31 | 5.44M shares 10-Q · filed 2021-05-07 |
| 2020-12-31 | 6.20M shares 10-K · filed 2021-02-25 |
| 2020-09-30 | 6.16M shares 10-Q · filed 2020-11-09 |
| 2020-06-30 | 5.92M shares 10-Q · filed 2020-08-07 |
| 2020-03-31 | 3.96M shares 10-Q · filed 2020-05-11 |
| 2019-12-31 | 5.71M shares 10-K · filed 2020-02-27 |
| 2018-12-31 | 4.14M shares 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |